Publications by authors named "Alexander Greenfield"

Claim this Profile
I
Identification of 3-sulfonylindazole derivatives as potent and selective 5-HT(6) antagonists.
Kevin G Liu, Albert J Robichaud, Alexander A Greenfield, Jennifer R Lo, Cristina Grosanu

Bioorg Med Chem· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tetrahydrocarbazole-based serotonin reuptake inhibitor/dopamine D2 partial agonists for the potential treatment of schizophrenia.
David P Rotella, Geraldine R McFarlane, Alexander Greenfield, Cristina Grosanu, Albert J Robichaud

Bioorg Med Chem Lett· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and biological activities of aryl-ether-, biaryl-, and fluorene-aspartic acid and diaminopropionic acid analogs as potent inhibitors of the high-affinity glutamate transporter EAAT-2.
Alexander Greenfield, Cristina Grosanu, John Dunlop, Beal McIlvain, Tikva Carrick

Bioorg Med Chem Lett· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of novel aryl-ether, biaryl, and fluorene aspartic acid and diaminopropionic acid analogs as potent inhibitors of the high-affinity glutamate transporter EAAT2.
John Dunlop, H Beal McIlvain, Tikva A Carrick, Brian Jow, Qiang Lu, Alexander Greenfield

Mol Pharmacol· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
WAY-855 (3-amino-tricyclo[2.2.1.02.6]heptane-1,3-dicarboxylic acid): a novel, EAAT2-preferring, nonsubstrate inhibitor of high-affinity glutamate uptake.
John Dunlop, Scott Eliasof, Gary Stack, H Beal McIlvain, Alexander Greenfield

Br J Pharmacol· November 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis